Senseonics Holdings, Inc. (NYSE:SENS) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET
Company Participants
Jeremy Feffer – LifeSci Advisors
Tim Goodnow – President and Chief Executive Officer
Rick Sullivan – Chief Financial Officer
Brian Hansen – President of CGM at Ascensia Diabetes Care
Conference Call Participants
Brian Langan – Morgan Stanley
Vernon Bernardino – H.C. Wainwright
Operator
Good day, everyone, and welcome to the Senseonics Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. Later you will have the opportunity to ask questions during the question-and-answer session. [Operator Instructions] Please note, this call may be recorded. I will be standing by if you should need any assistance.
It is now my pleasure to turn the conference over to Jeremy Feffer, LifeSci Advisors.
Jeremy Feffer
Thank you. This is Jeremy Feffer from LifeSci Advisors. Before we begin today, let me remind you that the company’s remarks include forward-looking statements. These statements reflect management’s expectations about future events, operating plans, regulatory matters, product enhancements, company performance and other matters and speak only as of the date hereof.
These forward-looking statements involve a number of risks and uncertainties. A list of these factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is detailed under Risk Factors and elsewhere in our annual report on Form 10-K for the year ended December 31, 2023, our quarterly report on Form 10-Q for the quarter ended September 30, 2024, and our other reports filed with the SEC. These documents are available in the Investor Relations section of our website at www.sensionics.com. We undertake no obligation to update publicly or revise these forward-looking statements for any reason except as required by law.
Joining me today from Senseonics
Read the full article here